FDA
フジドリームエアラインズ(FDA)は、航空機のコクピット窓に展張するサンシェードのデザインを一般公募...
FlyTeam
Washington (AFP) - The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage. Wegovy, produced by Danish pharmaceutical giant Novo Nordisk, was approved "to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight," the FDA said in a statement. The FDA's decision could be a game changer for the approximately 70 percent of American adults who it says are either obese or ...
AFP
フジドリームエアラインズ(FDA)は、2024年3月31日(日)から静岡/出雲線の運航を毎日1往復で...
FlyTeam
フジドリームエアラインズ(FDA)は、2024年のゴールデンウィークとお盆期間に運航する熊本/高知線...
FlyTeam
フジドリームエアラインズ(FDA)は2024年3月に引退する4号機、機体記号(レジ)「JA04FJ」...
FlyTeam
Legisladores y reguladores de Washington han empezado a plantearse cómo regular la inteligencia artificial (IA) en la atención de salud, y la industria de la IA cree que es muy probable que lo hagan mal. “Es un problema de enormes proporciones”, afirmó Bob Wachter que preside el Departamento de Medicina de la Universidad de California-San Francisco (UCSF). “Existe el riesgo de que se use artillería pesada y regulemos en exceso”. El impacto de la IA en el sector de salud ya es generalizado. La Administración de Alimentos y Medicamentos (FDA) ha aprobado unos 692 productos de inteligencia artifi...
Kaiser Health News (Espanol)
フジドリームエアラインズ(FDA)は、2月16日(金)より神戸空港行き対象路線の利用客を対象に、神戸...
ラジオ関西
Lawmakers and regulators in Washington are starting to puzzle over how to regulate artificial intelligence in health care — and the AI industry thinks there’s a good chance they’ll mess it up. “It’s an incredibly daunting problem,” said Bob Wachter, the chair of the Department of Medicine at the University of California-San Francisco. “There’s a risk we come in with guns blazing and overregulate.” Already, AI’s impact on health care is widespread. The Food and Drug Administration has approved some 692 AI products. Algorithms are helping to schedule patients, determine staffing levels in emerge...
Kaiser Health News
Lawmakers and regulators in Washington are starting to puzzle over how to regulate artificial intelligence in health care — and the AI industry thinks there’s a good chance they’ll mess it up. “It’s an incredibly daunting problem,” said Bob Wachter, the chair of the Department of Medicine at the University of California-San Francisco. “There’s a risk we come in with guns blazing and overregulate.” Already, AI’s impact on health care is widespread. The Food and Drug Administration has approved some 692 AI products. Algorithms are helping to schedule patients, determine staffing levels in emerge...
California Healthline
フジドリームエアラインズ(FDA)は、2024年3月31日(日)以降の夏ダイヤより名古屋(中部)/出...
FlyTeam
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら